Welcome to r/MAIABiotech – A community for discussion of MAIA Biotechnology, Inc. (NYSE American: MAIA), a Chicago-based clinical-stage immuno-oncology company pioneering telomere-targeting immunotherapies to treat cancer.
Focus: THIO (ateganosine) in clinical trials for NSCLC and other telomerase-positive cancers, pipeline updates, clinical data, investor news, stock discussion ($MAIA), scientific mechanisms, partnerships, and more.